Cargando…
The E6AP Binding Pocket of the HPV16 E6 Oncoprotein Provides a Docking Site for a Small Inhibitory Peptide Unrelated to E6AP, Indicating Druggability of E6
The HPV E6 oncoprotein maintains the malignant phenotype of HPV-positive cancer cells and represents an attractive therapeutic target. E6 forms a complex with the cellular E6AP ubiquitin ligase, ultimately leading to p53 degradation. The recently elucidated x-ray structure of a HPV16 E6/E6AP complex...
Autores principales: | Zanier, Katia, Stutz, Christina, Kintscher, Susanne, Reinz, Eileen, Sehr, Peter, Bulkescher, Julia, Hoppe-Seyler, Karin, Travé, Gilles, Hoppe-Seyler, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226571/ https://www.ncbi.nlm.nih.gov/pubmed/25383876 http://dx.doi.org/10.1371/journal.pone.0112514 |
Ejemplares similares
-
Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides
por: Stutz, Christina, et al.
Publicado: (2015) -
Viral E6/E7 oncogene and cellular hexokinase 2 expression in HPV-positive cancer cell lines
por: Hoppe-Seyler, Karin, et al.
Publicado: (2017) -
Ubiquitination of the HPV Oncoprotein E6 Is Critical for E6/E6AP-Mediated p53 Degradation
por: Li, Siying, et al.
Publicado: (2019) -
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
por: Martinez-Zapien, Denise, et al.
Publicado: (2016) -
HPV E6, E6AP and cervical cancer
por: Beaudenon, Sylvie, et al.
Publicado: (2008)